Patent intelligence · US
US 11172694
Core-shell structure with titanium dioxide core
Core-shell structure with titanium dioxide core
Patent details — US 11172694
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 16, 2021
- Expiration
- Nov 11, 2041
- Applicant
- SOLID CHEMICALS GMBH
- Claims
- 14
- CPC classes
- A61K, A61K33/00, A61K33/30, A61K9/5015
Quick answer
US 11172694 (Core-shell structure with titanium dioxide core) is held by SOLID CHEMICALS GMBH. Status: granted. Granted Nov 16, 2021. Expires Nov 11, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SOLID CHEMICALS GMBH
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K33/00, A61K33/30, A61K9/5015, A61P, A61P1/12
More from SOLID CHEMICALS GMBH
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 11172694?
US 11172694 (Core-shell structure with titanium dioxide core) is held by SOLID CHEMICALS GMBH. Status: granted. Granted Nov 16, 2021. Expires Nov 11, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11172694?
SOLID CHEMICALS GMBH is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 11172694 expire?
Our index shows an expiration date of Nov 11, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.